BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38100175)

  • 1. Neighborhood-level social determinants of health measures independently predict receipt of living donor liver transplantation in the United States.
    Kanneganti M; Byhoff E; Serper M; Olthoff KM; Bittermann T
    Liver Transpl; 2024 Jun; 30(6):618-627. PubMed ID: 38100175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/ethnic disparities in wait-list outcomes are only partly explained by socioeconomic deprivation among children awaiting liver transplantation.
    Wadhwani SI; Ge J; Gottlieb L; Lyles C; Beck AF; Bucuvalas J; Neuhaus J; Kotagal U; Lai JC
    Hepatology; 2022 Jan; 75(1):115-124. PubMed ID: 34387881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex and racial disparities in living donor liver transplantation in the United States.
    Duffey K; Halegoua-DeMarzio D; Shah AP; Tholey DM
    Liver Transpl; 2023 Nov; 29(11):1172-1180. PubMed ID: 37379011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
    Yankol Y; Bugeaud E; Zens T; Rizzari M; Mecit N; Leverson GE; Foley D; Mezrich JD; Kanmaz T; Andaçoğlu OM; D'Alessandro AM; Acarlı KS; Kalayoğlu M; Fernandez LA
    Turk J Med Sci; 2021 Apr; 51(2):610-622. PubMed ID: 33037873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA; Ascher NL; Freise CE; Dodge JL; Roberts JP
    Liver Transpl; 2012 Feb; 18(2):160-5. PubMed ID: 22006378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS; Ruebner RL; Abt PL
    Am J Transplant; 2015 Oct; 15(10):2732-8. PubMed ID: 25969133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization.
    Lentine KL; Tanaka T; Xiao H; Bittermann T; Dew MA; Schnitzler MA; Olthoff KM; Locke JE; Emre S; Hunt HF; Liapakis A; Axelrod DA
    Clin Transplant; 2023 Jul; 37(7):e14924. PubMed ID: 36733213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
    Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and ethnic disparities in access to and utilization of living donor liver transplants.
    Nobel YR; Forde KA; Wood L; Cartiera K; Munoz-Abraham AS; Yoo PS; Abt PL; Goldberg DS
    Liver Transpl; 2015 Jul; 21(7):904-13. PubMed ID: 25865817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
    Humar A; Ganesh S; Jorgensen D; Tevar A; Ganoza A; Molinari M; Hughes C
    Ann Surg; 2019 Sep; 270(3):444-451. PubMed ID: 31305283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single-Center Analysis.
    Leung KK; Kim A; Hansen BE; Lilly L; Selzner N; Patel K; Bhat M; Hirschfield GM; Galvin Z
    Liver Transpl; 2021 Dec; 27(12):1733-1746. PubMed ID: 34092028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC; Fung JY; Pang HH; Leung CK; Li HF; Sin SL; Ma KW; She BW; Dai JW; Chan AC; Cheung TT; Lo CM
    Hepatology; 2021 Jun; 73(6):2441-2454. PubMed ID: 33006772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.
    Bowring MG; Zhou S; Chow EKH; Massie AB; Segev DL; Gentry SE
    Transplantation; 2019 Oct; 103(10):2113-2120. PubMed ID: 30801545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Living Donor Liver Allografts Fail: Exploring the Outcomes of Retransplantation Using Deceased Donors.
    Bittermann T; Shaked A; Goldberg DS
    Am J Transplant; 2017 Apr; 17(4):1097-1102. PubMed ID: 27596956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
    Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
    Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.
    Freise CE; Gillespie BW; Koffron AJ; Lok AS; Pruett TL; Emond JC; Fair JH; Fisher RA; Olthoff KM; Trotter JF; Ghobrial RM; Everhart JE;
    Am J Transplant; 2008 Dec; 8(12):2569-79. PubMed ID: 18976306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.